MultiPark: Multidisciplinary research focused on Parkinson´s disease
321 – 330 of 3876
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
α-Synuclein induces deficiency in clathrin-mediated endocytosis through inhibiting synaptojanin1 expression
(
- Contribution to journal › Article
-
Mark
Centrally and peripherally altered glucose transporters : is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Head-to-head comparison of relative cerebral blood flow derived from dynamic [18F]florbetapir and [18F]flortaucipir PET in subjects with subjective cognitive decline
(
- Contribution to journal › Article
-
Mark
Performance of a [18F]Flortaucipir PET Visual Read Method Across the Alzheimer Disease Continuum and in Dementia with Lewy Bodies
(
- Contribution to journal › Article
-
Mark
Proteomic Determinants of Variation in Cholesterol Efflux : Observations from the Dallas Heart Study
(
- Contribution to journal › Article
-
Mark
Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
(
- Contribution to journal › Article
-
Mark
The association of copeptin with metabolic risk markers is modified by region of origin
(
- Contribution to journal › Article
-
Mark
Frontotemporal demenssjukdom
2023) p.38-55(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Brain fingerprinting using EEG graph inference
2023) 31st European Signal Processing Conference, EUSIPCO 2023 In European Signal Processing Conference p.1025-1029(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
APOE Genotype in the Era of Disease-Modifying Treatment with Monoclonal Antibodies Against Amyloid-β
(
- Contribution to journal › Debate/Note/Editorial